Dark

Check out our API

BOLD
Boundless Bio, Inc. Common Stock
stock NASDAQ

At Close

Oct 2, 2026 3:59:51 PM EDT

2.63USD+1.544%(+0.04)156,529

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 1, 2026 8:04:30 AM EDT

2.48USD-4.247%(-0.11)0

After-hours

Sep 29, 2026 4:25:30 PM EDT

2.60USD+1.563%(+0.04)0

Overview HistoricalExchangesShortsNews

Dec 27, 2020

02:34AM EST Audentes Therapeutics, an Astellas genetic medicines company, said that the U.S. Food and Drug Administration lifted the clinical hold for the ASPIRO clinical trial evaluating AT132 in patients with X-linked myotubular myopathy. RTTNews

Share